Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Int Adv Otol ; 14(3): 484-487, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30411708

ABSTRACT

Bacterial meningitis may cause inner ear fibrosis and progressive cochlear ossification with irreversible profound hearing loss (HL). Recognition of potential ossification is essential for effective management. We present a clinical case of a 4 year old boy who developed a progressive HL starting 3 weeks after meningitis. For the prospective risk of cochlear ossification, bilateral cochlear implantation (CI) was performed. Unexpectedly, unaided hearing threshold began to show improvement on the left ear, starting 4 months after meningitis and continuing for years post CI surgery. In order to explore the residual cochlear function, a trial of exclusively acoustic amplification was performed on the improved left side 5 years post implantation, providing good results. A certain degree of hearing recovery may be expected after meningitis related deafness. This case encourages surgeons to always adopt atraumatic surgical techniques that can enable the preservation of cochlear structure and residual function after CI surgery.


Subject(s)
Auditory Threshold/physiology , Cochlea/physiopathology , Cochlear Implantation , Hearing Loss/physiopathology , Meningitis, Bacterial/complications , Child, Preschool , Hearing Loss/microbiology , Hearing Loss/surgery , Humans , Male , Postoperative Period
2.
Eur J Med Chem ; 108: 542-552, 2016 Jan 27.
Article in English | MEDLINE | ID: mdl-26717204

ABSTRACT

With the aim to identify new, potent and selective monoamine oxidase B (MAO-B) inhibitors, molecular interaction field analysis has been applied to a MAO-B complex with 3-acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazole chemical structure, known as a privileged scaffold for this target. Several compounds displayed potent in vitro activity, exhibiting IC50 values in the medium to low nanomolar range. The enantiomers of most promising derivatives were separated by enantioselective HPLC and in vitro evaluated. Experimental results, according to theoretical drug design, clearly indicated a key role of the ligand stereochemistry in the target recognition/inhibition. In particular the (R)- enantiomers showed the best activity with respect to the (S)- stereoisomer. Finally, docking experiments coupled to molecular dynamics (MD) simulations, were applied for understanding the putative MAO -B binding modes of the new compounds providing detailed information for further structural optimization.


Subject(s)
Drug Design , Monoamine Oxidase Inhibitors/pharmacology , Monoamine Oxidase/metabolism , Oxadiazoles/pharmacology , Computer Simulation , Dose-Response Relationship, Drug , Humans , Molecular Dynamics Simulation , Molecular Structure , Monoamine Oxidase Inhibitors/chemical synthesis , Monoamine Oxidase Inhibitors/chemistry , Oxadiazoles/chemical synthesis , Oxadiazoles/chemistry , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...